S. 4810

S. 4810: A bill to establish a grant program for education related to semiconductor manufacturing and related industries.

Introduced Mark Kelly (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4810 is a bill aimed at creating a grant program to support education and training in semiconductor manufacturing and related industries. The goal is to enhance the workforce's skills and knowledge in this critical sector, which is vital for technological advancement and economic growth.

Positive Media Summary

Media outlets have praised S. 4810 for its proactive approach to addressing the skills gap in the semiconductor industry. Supporters argue that the bill will help ensure a well-trained workforce, stimulate job creation, and strengthen the U.S. position in global technology markets.

Negative Media Summary

Critics of S. 4810 express concerns about the potential for misallocation of funds and question whether the grant program will effectively address the underlying challenges facing the semiconductor industry. Some argue that more immediate solutions are needed rather than focusing on education and training.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Science, Technology, Communications

The analysis of Bill S. 4810, which aims to establish a grant program for education related to semiconductor manufacturing, reveals no direct industry overlaps between the sponsor Mark Kelly's top donor industries and the bill's subject matter. The top donor industries do not include any semiconductor or technology-related sectors, indicating a low likelihood of conflicts of interest. The lobbying activity related to this bill primarily involves healthcare and telecommunications sectors, which are not directly connected to semiconductor manufacturing. The largest contributions from entities like Vertex Pharmaceuticals ($60,000) and Intermountain Health ($50,000) further emphasize this disconnect, as they focus on healthcare rather than technology. Therefore, voters can be reassured that the financial support for the sponsor does not appear to influence the legislative intent of this bill significantly.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
INTERMOUNTAIN HEALTH MCDERMOTT WILL & SCHULTE LLP $50,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
FRONTIER INFRASTRUCTURE HOLDINGS LLC KOUNTOUPES DENHAM CARR & REID, LLC $30,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us